These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 22068461

  • 21. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL, Wang RY.
    J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
    [Abstract] [Full Text] [Related]

  • 22. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML, Wiker C, Svensson TH.
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
    [Abstract] [Full Text] [Related]

  • 23. NMDA and AMPA/kainate glutamatergic agonists increase the extracellular concentrations of GABA in the prefrontal cortex of the freely moving rat: modulation by endogenous dopamine.
    Del Arco A, Mora F.
    Brain Res Bull; 2002 Mar 15; 57(5):623-30. PubMed ID: 11927365
    [Abstract] [Full Text] [Related]

  • 24. Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment.
    Tarazi FI, Baldessarini RJ, Kula NS, Zhang K.
    J Pharmacol Exp Ther; 2003 Sep 15; 306(3):1145-51. PubMed ID: 12829726
    [Abstract] [Full Text] [Related]

  • 25. Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study.
    Gemperle AY, Enz A, Pozza MF, Lüthi A, Olpe HR.
    Neuroscience; 2003 Sep 15; 117(3):681-95. PubMed ID: 12617972
    [Abstract] [Full Text] [Related]

  • 26. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR, Vanover KE, Pounds L, Johnson RW, Barido R, Anderson GT, Veinbergs I, Dyssegaard A, Brunmark P, Tabatabaei A, Davis RE, Brann MR, Hacksell U, Bonhaus DW.
    J Pharmacol Exp Ther; 2007 Aug 15; 322(2):862-70. PubMed ID: 17519387
    [Abstract] [Full Text] [Related]

  • 27. Riluzole, a glutamate release inhibitor, and motor behavior.
    Kretschmer BD, Kratzer U, Schmidt WJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug 15; 358(2):181-90. PubMed ID: 9750003
    [Abstract] [Full Text] [Related]

  • 28. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z, Huang M, Prus AJ, Dai J, Meltzer HY.
    Brain Res; 2007 Feb 23; 1134(1):70-8. PubMed ID: 17207474
    [Abstract] [Full Text] [Related]

  • 29. Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
    Li M, He W, Mead A.
    Behav Pharmacol; 2009 Feb 23; 20(1):84-98. PubMed ID: 19179852
    [Abstract] [Full Text] [Related]

  • 30. Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro.
    Arvanov VL, Liang X, Schwartz J, Grossman S, Wang RY.
    J Pharmacol Exp Ther; 1997 Oct 23; 283(1):226-34. PubMed ID: 9336328
    [Abstract] [Full Text] [Related]

  • 31. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
    Leonetti M, Desvignes C, Bougault I, Souilhac J, Oury-Donat F, Steinberg R.
    Neuroscience; 2006 Oct 23; 137(2):555-64. PubMed ID: 16289893
    [Abstract] [Full Text] [Related]

  • 32. Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord.
    Bradaïa A, Schlichter R, Trouslard J.
    J Physiol; 2004 Aug 15; 559(Pt 1):169-86. PubMed ID: 15235081
    [Abstract] [Full Text] [Related]

  • 33. Synergistic interactions between ampakines and antipsychotic drugs.
    Johnson SA, Luu NT, Herbst TA, Knapp R, Lutz D, Arai A, Rogers GA, Lynch G.
    J Pharmacol Exp Ther; 1999 Apr 15; 289(1):392-7. PubMed ID: 10087029
    [Abstract] [Full Text] [Related]

  • 34. Effect of Sarcosine (a Glycine Transport 1 Inhibitor) and Risperidone (an Atypical antipsychotic Drug) on MK-801 Induced Learning and Memory Deficits in Rats.
    Kumar V, Ahmad MA, Najmi AK, Akhtar M.
    Drug Res (Stuttg); 2016 Jan 15; 66(1):11-7. PubMed ID: 25710578
    [Abstract] [Full Text] [Related]

  • 35. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
    Qiao J, Zhang Q, Li M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():177-85. PubMed ID: 24140929
    [Abstract] [Full Text] [Related]

  • 36. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
    Wadenberg ML, Fjällström AK, Federley M, Persson P, Stenqvist P.
    Int J Neuropsychopharmacol; 2011 Jun 03; 14(5):644-54. PubMed ID: 20701827
    [Abstract] [Full Text] [Related]

  • 37. Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex.
    Chen L, Yang CR.
    J Neurophysiol; 2002 May 03; 87(5):2324-36. PubMed ID: 11976371
    [Abstract] [Full Text] [Related]

  • 38. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M, Shirakawa K, Matsuoka N, Mutoh S.
    Psychopharmacology (Berl); 2004 Oct 03; 176(1):94-100. PubMed ID: 15083255
    [Abstract] [Full Text] [Related]

  • 39. Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex.
    Carli M, Calcagno E, Mainolfi P, Mainini E, Invernizzi RW.
    Psychopharmacology (Berl); 2011 Apr 03; 214(3):639-52. PubMed ID: 21052982
    [Abstract] [Full Text] [Related]

  • 40. Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.
    Marcus MM, Björkholm C, Malmerfelt A, Möller A, Påhlsson N, Konradsson-Geuken Å, Feltmann K, Jardemark K, Schilström B, Svensson TH.
    Eur Neuropsychopharmacol; 2016 Sep 03; 26(9):1401-1411. PubMed ID: 27474687
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.